Drugs / 31001074
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01159821 | Aug → Oct 2010 | — | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 31001074 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01159821 ↗ |
| Route | Oral | “after paroxetine and 31001074 are administered orally (by mouth)” NCT01159821 ↗ |